International Scholarly Research Notices / 2011 / Article / Tab 2

Review Article

Evaluating Smoking Cessation Interventions and Cessation Rates in Cancer Patients: A Systematic Review and Meta-Analysis

Table 2

Tobacco smoking cessation intervention characteristics.

Author, year (Ref)No. of ptsSmoking typeCurrent smokersCigarettes smoked/day ± SDRandomization characteristics
Usual care (no. of pts)Intervention (no. of pts)Cessation interventionConfirmation of non-smoking
SettingNon-pharmacologicalPharmacological

Schnoll et al. 2003 [4]74Tobacco7 4 a NRcounselingnicotine replacement therapySelf-report
Wakefield et al. 2004 [11]246Tobacco24617.5 ± 9.6132118noneNicotine replacement therapy, buproprionSelf report and breath CO
Gritz et al. 2006 [12] 137Tobacco135I: 21.7 ± 12.1, U: 21.4 ± 10.96374motivational interviewing, smoking cessation booklets, family advice to quitnicotine replacement therapySelf-report, breath CO and urine continine levels
Wewers et al. 1994 [13]184Tobacco136NR9193Cognitive behavioral therapynicotine replacement therapy and buproprionSelf-report
Gritz et al. 1993 [1]186Tobacco96C: 24.0 ± 12.4, U: 21.4 ± 11.34650clinicCounseling, bookletsnoneSelf-report, urine continine levelse
Rothman and Greenland 1998 [15]30Tobacco30I: 19.1 ± 7.7, U: 23.4 ± 9.61614Post-operative, in-hospitalCounseling, cessation booklets,noneSelf-report and saliva continine levelsb,c
Greenland and Robins 1985 [16]28Tobacco28I: 24.7 ± 14.5, U: 27.0 ± 19.81818In-hospital, during hospitalization, pre-operativeCounseling, bookletsnoneSelf-report and saliva continine levelsd
Griebel et al. 1998 [17]109Tobacco108I: 19.2 ± 12.3, U: 17.5 ± 11.25752CounselingNicotine replacement therapySelf-reported

I, intervention; U, usual care, NR: not reported; CO: carbon monoxide
a smoking within 6 months of diagnosis
b saliva continine level of ≤10.0 ng/mL
c 1 patient declined saliva continine level
d saliva continine level of ≤14.0 ng/mL
e urine continine level of ≤50 ng/mL.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.